Earnings Call · Q3 FY2022·2022-10-27

Q3 22EPS +10.16%·Rev n/aQ2 22EPS +2.86%·Rev n/aQ1 22EPS -0.56%·Rev n/aQ4 21EPS +2.43%·Rev n/a⚠ consensus missing

VERTEX PHARMACEUTICALS INC / MA VRTX

Susie Lisa — Senior Vice President, Investor Relations

Dr. Reshma Kewalramani — Chief Executive Officer (CEO)

Stuart Arbuckle — Chief Operating Officer (COO)

Charlie Wagner — Chief Financial Officer (CFO)

Unidentified Analyst — Analyst

Mohit Bansal — Analyst

+9.0%1d on move date+6.7% vs SPY3d+9.1%5d+8.1%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VRTX calls or request research access.

More VRTX calls Browse calls Request research access